Thanks, and order solution performance, everything undertaking Philips. the very joining can. the heart and and patients we obviously huge three strategy to QX backdrop; delivery do operational and our remains our environment; that Philips at at inflationary this an fast one, to deliver shortages shaping the to we at the dislocation as factors morning. supply the three, Respironics a in There everything results chain, well-being geopolitical increasing are challenges of Yes. everyone, of caregivers and today. and Patient the as do affected to us continued thanks, and it's book strong are Number despite leading increased outlook for challenging Leandro two
three Now, factors. me let these unpack
This for for strengths driven & order further continue businesses, growth excluding quarters, in Our quarter & book products Informatics, across customers very X% our group Hospital ago, experienced Care Treatment and presentation. equipment to and demand solid than and Care business, or by consumers higher Respiratory year strategy Diagnosis in Monitoring the on with Order intake the the Patient resulting XX% on solutions. our Connected Sleep and the grew all-time recent X%, we Page again shown builds intake name than and few. well the portfolio XX in high a an for Philips, as good a more fact order to of just in resonate
world, staff our outcomes, Hainan of During hospital signed first provide Shanghai the patient ability also with signed more in Also, and care, partnerships we cost critical the and experience. the leaders China, an provinces Shandong in in Personal propositions the decline. to hospitals people, of our to for range am and advanced XX sales. to we lower demonstrating imaging broad demonstrates the long-term single-digit with these improve trust segment. of health businesses East sales a the enhance care solutions. the a sales our agreement with quarter, exceeded demand guidance in high hard for which Thanks Health with comparable X% quarter in I we challenging sales EBITA work decline recorded pleased Adjusted our comparable a X% of billion of growth which this of €X.X X.X% prior them its Hospital strategic have our the consumer strong circumstances also across help was in
supply the now, shortage severe related and primarily electronic chain across suppliers. affecting disruptions increased again, components, to We continue shipping our of to businesses times face COVID
spot actions suppliers are the and the management taking mitigate We expect the long-term quarters We with decisive coming our orders headwinds we to buying. these impact. but expanded continue had increased daily to in already with
of health sourcing product calling at on components. the levels are suppliers and to designs adjusting of prioritize supply teams R&D senior components. governments products we Our to are diversify Moreover, in care
we effects of lack difficult availability visibility forecast some poor which While remains accurately. in these makes positive from to component suppliers to actions, of visibility due see
chain lockdowns measures the these pose overall and sales implementing the Russia-Ukraine mounting on has in for on about for leads current which war our we far effect headwinds. global are well pressure, additional geopolitical supply concerned which small revenues as continue as are strongly both chain. in of to additional the for China and We condemn, to terms uncertainty price The domestic and year macroeconomic, taking situation negative inflationary to the the the year monitor we The a outlook mitigate so closely. cost also we supply increases environment so
Respironics the about speak me recall. let Now,
to patients repair dedicated sleep our are kits to and As I The replacement date. have X.X needs. committed deeply are and we patient and community of more to on than solutions respiratory is physicians globally care and who meeting customers and repair million supporting the program underway replacement we produced and said, who rely devices the
months to costs. increased more been volume which further than chain recorded the over global last increases works. devices field there challenges. supply €XX and eligible two quarters, and Since the device registration a have provision process of are to weekly remediation quarter output despite higher in accelerating how is have is mainly related the explain a it for million expected recent in increase We higher important our the communication threefold over We the production action
customers, United hence, the quantities their the the in equipment owned an ownership transfers CPAP In States, be to durable initial the fairly patient. after markets rental the devices view providers. have is For we to our of installed base. by of remediated equipment States, outside period, medical United accurate most And of the
patients the of be this unless existing a units looks the for we the that result, regression to model which make weekly is of total project registrations a likely at reason It to patient estimation. have that number registers an challenging accurate remediated. used very need pattern to it's the will units, As
in registrations the extensive there an see will remediated. can of daily be the regression us our the on anticipate recall, has led revise around U.S. now increase increase the there to was mid-February, presentation, reduced. based to communication registrations XXX,XXX you which from model which need on when This in As chart XX Page units we number additional an of subsequently around was which
the to the of complete number we customers of to expect over in XX% XXXX. and production Given increased now devices, shipment
reiterate to fast that patients the in possible. recorded a place €XXX a for higher of get cost speed to as a is provision million further of strive we speed. have action with as strong ensure I we program like environment to Additionally, executed a the was potentially would ensure in as solution to and to management execution, pressures the as such program inflationary volatile field
last strong working team leadership the a of we Roy Jakobs. I time, under have explained As
Quality for We Regulatory ensuring have teams changes well place affair These Sleep & issue are laser throughout XXXX. procedures made and on Respiratory teams responsibility management's strengthened whilst airtight oversight in as in focused resolving legacy organizational the Care the as are with this future. & in
and Philips. We bolstered around have medical also surveillance, post-market and staffing toxicology expertise within affairs, biocompatibility
is know, in you and lawsuits claims. Philips As class-action injury individual defendant several Respironics personal a
quarter. associated update test important. draw testing on is use is ultimate its of program the this plan As Ultimately, litigation we risks second are the a the the in comprehensive devices. to conclusions be the to still conducting will know, it science outcomes. We in as with to characterize any you potential And very early provide too an the on stages, early
the moment for done already the as relevant, cross-check between almost learnings referenced work the does this the on any show be foundation We enterprise. pivotal the improvements made and study patient we cancer should the of years, Respironics over also on focus and use occurrence recall, Canadian already across patients it material epidemiological users. not Building reinforce from sleep of reassuring on the X,XXX safety and amongst across based which to an of recent correlation devices the are the company using quality where to study
portfolio recorded the voluntary a Connected customers Care earlier at and past a ones in and actions with stepped lines all well-defined announced alignment to the further since mentioned are that not incidents in discovery the in Last significant which we in also over year. smaller globally additional provision under severe reviewing scope. scrutiny quality in complaints field earlier. have execution quarter, products issues up and to recalls already and I two are We relation led Both with relooked the business regulators has of have
to up on to allegations. the subpoena events work for support to At in is follow clarify not we closely subsidiaries Respironics and circumstances inspectional related Importantly, of for the no Receiving certain engage the information Department recall. received not information other provide U.S. information aware Respironics FDA, subject. on the is subpoena on and these investigation Philips U.S. leading focused any cooperating. Respironics with information this and the time, from specific a in we there's out and a continue to regulators this the and in request and Justice Philips requests United globally, request further time, At of Philips findings this a the including are of Respironics the their the to States recently to subsidiaries ordinary. are fully XXX. Form point under
clarification have the progress. As mentioned, details asked on we Leandro published on the recall frequently to provide FAQs, and questions,
information are this particularly provide website. Relations details on are at the not our to we There to You also find litigation able on areas will Investor where and topic the some related further presentation time.
timely in as manner situation information and We will share the a transparent evolves.
color Lumify, wide on expanded applications, are range our with obstetrics some first how hospital and of in future. Ultrasound capabilities flow cardiology, supporting measurement leaders for to globe of the the our clinicians hemodynamic In we advanced we leading I today's gynecology. blood the as handheld quantify ultrasound, like point-of-care a Now, to would on including portfolio plan they across provide needs the quarter, enabling
in growth Diagnostic first quarter, enjoyed the Informatics we During Enterprise strong our portfolio.
in to, and multiple entered enables between to Next and for remote imaging Operations solutions, partnerships providers, productivity teams radiologists care vendor-neutral our U.K. our CT-based imaging of deliver MR- and technologists, Command also across we suite customers with diagnoses. Center example, collaboration sites, among several into the enterprise access and Radiology which which helping thereby to expand to winning increase for operation health several Germany,
once MR double-digit order intake growth quarter share gains. delivered in and again the deliver Our to market business continued strong,
oncology Belgium, lung immediately team Based our procedures Image-Guided accuracy In installed Diagnosis success fact, our in biopsy we our lung option Ingenia & cancer successfully interventional Lung to U.K. and Suite cancer enhances the solution In Treatment on highlighting called France, helium-free in into therapy expanding installation to the provides XXX of portfolio. date, this Israel early-stage Ambition Philips a of unique and MRI Therapy, Azurion, more treat solution are with of the the than patients. systems
in Therapy of for and we in invest innovation. smart strong, new pressure XX% core We solutions suite and quarter design double-digit strong growth a SXXXX in with see driving to making sales of game range China. which our the we X% new Moreover, SkinIQ efficacy. our cleaning co-registration OmniWire We comparable the and X% quarter sales the off, toothbrushes with and speed Health, combines America of refresh well coupled demand to interdental as is strong of as This ahead, performance, XX North devices. order for further. deteriorate our recent customer and and result electric for with that strong which XX% procedures, Healthcare in entry-range our it impact volumes round sales and innovative support solid are to same first COVID-XX may the strong accounts provided is January. convert growth a is introduction At recognize devices, compatibility, strong wire growth global category. the Philips of margin in to in situation, In points adjusted successful to sales already is OmniWire time, the Personal the XX the interventional book which the premium-range adopting and very supply it launch continue performance the risk first book, portfolio of traction this recorded if a our to war, continue physiology our for our world's chain the Shaver pressures products example delivers see and and we looking margin completed is Oral with which accelerated basis changer ability our growth potentially to uplift To improvement to iFR the our related of see important challenges EBITA as easy-to-use iFR-proven our that the the throughout sales Image-Guided target which order outcomes increasing workhorse achieve Russia-Ukraine case. of conditions business year, inflationary
cost risks. on measures supply Our as implementing chain on execution, mitigate book however, fully Moreover, teams, and are the addressing strong price demand focused everyday and increases are the are delivering inflationary well we additional to order customer headwinds. the as
course, as as provide or color of appropriate further year the updates will, progresses. We
remain our technology potential leadership create and Our and to confident I health in grow continues journey to value. about
relevant we Our that customers them portfolio. very and stronger-than-ever to tell we us are have a
We we are fully growth to and margin excellence are manage the to the and execution near-term facing on headwinds in operational focused and term. medium higher unlock that
before, you, mentioned in plan Abhijit. color provide performance our to road we I As medium-term more map Over the summer. on to
